SEC Form D private-offering filing

Alveus Therapeutics, Inc.

Name: Alveus Therapeutics, Inc. - new SEC Form D private-offering filing, Philadelphia, PA
Published: 2026-01-14

A new SEC Form D private-offering notice from Philadelphia, PA, a $110,724,980 filer-stated offering target in Biotech. The source filing is one click away.

Alveus Therapeutics, Inc. site↗ Verified via SEC Form D

Clinical stage biotech developing GLP-1/GIPR fusion protein therapies for obesity and metabolic disease.

Filed 2026-01-14Filed to raise $110,724,980First money in 2025-12-22Raised so far $56,862,480HQ (as filed) Philadelphia, PASector Biotech ✓Stage (inferred) LateCall status Delayed filing

Source linked the Form D on EDGAR↗Website verified alveustx.com↗Named in the filing 8 executives & directors

Open this row on the live feed →More new filings in Pennsylvania →More Biotech filings →

This is a public SEC Form D private-offering notice, the filer's own statement to the SEC. Amounts are offering targets, not confirmed closes. Takeoff Radar pulls Form D nightly from EDGAR and links every filing to its source.